Trial Profile
To compare the efficacy of Bevacizumab and clinical features in patients with macular edema following branch retinal vein occlusion startified by baseline visual acuity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- 28 Aug 2017 New trial record